Pharmaceutical composition comprising NKT-activated NKT cells and their use in therapy

摘要

A pharmaceutical composition (A) comprises natural killer T cells (NKT) activated by a phosphatidylinositol mannoside (PIM), and a carrier. An Independent claim is also included for activating NKT ex vivo by treating a sample containing them with PIM.